Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interest (original) (raw)
References
Allard P, Bernard P, Fradet Y and Têtu B. . 1998 Br. J. Urol.81: 692–698.
Allard P, Fradet Y, Têtu B and Bernard P, Quebec Urology Research Group. . 1995 Clin. Cancer Res.1: 1195–1202.
Bartlett JMS, Watters AD, Ballantyne SA, Going JJ, Grigor KM and Cooke TG. . 1998 Br. J. Cancer77: 2193–2198.
Bartlett JMS, Watters AD, Martin S, Going JJ, Grigor KM and Cooke TG. . 1997 Ann. Hum. Genet.61: 207–208.
Clayton D and Hills M. . 1993 Statistical Models in Epidemiology. Oxford University Press: Oxford. Google Scholar
Czerniak B, Chaturvedi V, Li L, Hodges S, Johnston D, Ro JY, Luthra R, Logothetis C, Von Eschenbach AC, Grossman HB, Benedict WF and Batsakis JG. . 1999 Oncogene18: 1185–1196.
Dalbagni G, Presti J, Reuter V, Fair WR and Cordon-Cardo C. . 1993 Lancet342: 469–471.
Erbersdobler A, Friedrich MG, Schwaibold H, Henke RP and Huland H. . 1998 Oncol. Res.10: 415–420.
Gailani MR, Stahle-Backdahl M, Leffell DJ, Glynn M, Zaphiropoulos PG, Pressman C, Unden AB, Dean M, Brash DE, Bale AE and Toftgard R. . 1996 Nat. Genet.14: 78–81.
Habuchi T, Devlin J, Elder PA and Knowles MA. . 1995 Oncogene11: 1671–1674.
Habuchi T, Luscombe M, Elder PA and Knowles MA. . 1998 Genomics48: 277–288.
Hornigold N, Devlin J, Davies AM, Aveyard JS, Habuchi T and Knowles MA. . 1999 Oncogene18: 2657–2661.
Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, Quinn AG, Myers RM, Cox DR, Epstein Jr EH and Scott MP. . 1996 Science272: 1668–1671.
Keen AJ and Knowles MA. . 1994 Oncogene9: 2083–2088.
Kleinbaum DG, Kupper LL and Muller KE. . 1987 Applied Regression Analysis and Other Multivariate Methods. PWS-Kent publishing: Boston. Google Scholar
Larue H, Allard P, Simoneau M, Normann S, Pfister C, Moore L, Meyer F, Têtu B and Fradet Y. . 2000 Carcinogenesis21: 101–106.
Lee E, Schwaibold H, Fradet Y, Huland E and Huland H. . 1997 J. Urol.157: 1070–1073.
Liggett Jr WH and Sidransky D. . 1998 J. Clin. Oncol.16: 1197–1206.
Micheli A, Mariotto A, Rossi AG, Gatta G and Muti P. . 1998 Eur. J. Cancer34: 2271–2278.
Orlow I, Larue H, Osman I, Lacombe L, Moore L, Rabbani F, Meyer F, Fradet Y and Cordon-Cardo C. . 1999 Am. J. Pathol.155: 105–113.
Powell I, Tyrkus M and Kleer E. . 1990 Cancer Genet. Cytogenet.50: 97–101.
Rao JY, Hemstreet GP, Hurst RE, Bonner RB, Jones PL, Min KW and Fradet Y. . 1993 Proc. Natl. Acad. Sci. USA90: 8287–8291.
Sandberg AA and Berger CS. . 1994 J. Urol.151: 545–560.
Sharpless NE and Depinho RA. . 1999 Curr. Opin. Genet. Dev.9: 22–30.
Simoneau AR, Spruck III CH, Gonzalez-Zulueta M, Gonzalgo ML, Chan MF, Tsai YC, Dean M, Steven K, Horn T and Jones PA. . 1996 Cancer Res.56: 5039–5043.
Simoneau M, Aboulkassim TO, Larue H, Rousseau F and Fradet Y. . 1999 Oncogene18: 157–163.
Spruck CH, Ohneseit PF, Gonzalezzulueta M, Esrig D, Miyao N, Tsai YC, Lerner SP, Schmutte C, Yang AS, Cote R, Dubeau L, Nichols PW, Hermann GG, Steven K, Horn T, Skinner DG and Jones PA. . 1994 Cancer Res.54: 784–788.
Tsai YC, Nichols PW, Hiti AL, Williams Z, Skinner DG and Jones PA. . 1990 Cancer Res.50: 44–47.
Uchida T, Wang C, Wada C, Iwamura M, Egawa S and Koshiba K. . 1996 Int. J. Cancer69: 142–145.
Van Tilborg AAG, Hekman ACP, Vissers KJ, van der Kwast TH and Zwarthoff EC. . 1998 Int. J. Cancer75: 9–14.
Zhang L, Cui X, Schmitt K, Hubert R, Navidi W and Arnheim N. . 1992 Proc. Natl. Acad. Sci. USA89: 5847–5851.
Zhang ZF, Shu XM, Cordon-Cardo C, Orlow I, Lu ML, Millon TV, Cao PQ, Connolly-Jenks C, Dalbagni G, Lianes P, Lacombe L, Reuter VE and Scher H. . 1997 Cancer Epidemiol. Biomarkers Prev.6: 321–326.
Zhang ZF and Steiner G. . 1997 Principles and Practice of Genitourinary Oncology. Raghavan D, Scher HI, Leibel SA, Lange PH (eds). Lippincott-Raven: Philadelphia pp 215–222.
Zhao J, Richter J, Wagner U, Roth B, Schraml P, Zellweger T, Ackermann D, Schmid U, Moch H, Mihatsch MJ, Gasser TC and Sauter G. . 1999 Cancer Res.59: 4658–4661.